vaccination – Medxy AI

Kidney-transplant recipients benefit from COVID-19 vaccination

By MedXY 08/20/2025

Kidney-transplant recipients on long-term kidney replacement therapy demonstrate significant reductions in COVID-19-related hospitalizations and mortality following three or more vaccine doses, supporting booster vaccinations in this vulnerable population.

Clinical Updates Infectious Diseases news Respiratory Specialties

COVID reinfection may raise risk of persistent symptoms by 35%

By MedXY 08/20/2025

Observational data from the RECOVER Initiative suggest that SARS-CoV-2 reinfection raises the risk of long COVID by 35% relative to single infections, with more recent vaccination potentially mitigating this risk.

Family Medicine & Nutrition Medical News Neurology news Specialties

Can Preventing Herpes Reduce Dementia Risk? New Science Links Cold Sores, Shingles, and Alzheimer’s Disease

By MedXY 08/04/2025

Emerging research reveals a compelling connection between common herpes viruses and dementia risk, with vaccination and antiviral treatments showing promise for prevention.

Medical News Neurology news Specialties

Can Preventing Herpes Reduce Dementia Risk? New Science Links Cold Sores, Shingles, and Alzheimer’s Disease

By MedXY 08/04/2025

Emerging research reveals a compelling connection between common herpes viruses and dementia risk, with vaccination and antiviral treatments showing promise for prevention.

Medical News news Public Health Specialties

Declining Vaccination Rates Among US Kindergarteners: A Growing Public Health Concern

By MedXY 08/02/2025

Vaccination rates for US kindergarteners have declined for the third consecutive year, raising public health concerns. Experts attribute this trend to increased vaccine hesitancy and misinformation.

news OB/GYN & Women's Health Specialties

Evaluating HPV Vaccination Schedules: A New Perspective on Booster Doses

By MedXY 07/29/2025

Recent research suggests that a 2-dose HPV vaccine regimen offers similar long-term protection against HPV-16 and HPV-18 as the 2+1-dose regimen, challenging the necessity of booster doses.